78 results about "Anterior rhinorrhea" patented technology

The present invention relates to compositions that comprise an expectorant, an extended release antitussive, and an extended release decongestant. Specifically, the compositions comprise guaifenesin, phenylephrine tannate, and dextromethorphan tannate. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and / or nasal obstruction.

The present invention relates to compositions comprising an antitussive, a decongestant and an expectorant, and in a specific embodiment comprising hydrocodone, phenylephrine hydrochloride and guaifenesin, wherein the composition may be substantially free of added sugar and added alcohol, and methods for using these compositions for the treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and / or nasal obstruction.

A solid pharmaceutical dosage unit for alleviating the symptoms of rhinorrhea. The dosage unit comprises an anticholinergic agent and an antihistamine and, optionally, a decongestant and, when placed in a basket in 500 ml of 0.01 N HCl of 37° C. which is stirred at 100 rpm, releases at least about 75% of the at least one anticholinergic agent within 45 minutes and releases the at least one antihistamine at a rate of from about 20% to about 60% after 2 hours, from about 45% to about 80% after 4 hours and at least about 75% after 8 hours. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.

New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably, the composition comprises ipratropium or a salt thereof in combination with xylometazoline hydrochloride and a salt thereof. Upon topically administering such compositions to a nasal mucosa in individuals suffering from the common cold the symptoms of rhinorrhea are significantly reduced.

The present invention relates to compositions that comprise immediate release and extended release guaifenesin, extended release phenylephrine and immediate and extended release dextromethorphan. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and / or nasal obstruction.

The invention relates to herbal tea for expelling wind and heat. A Chinese medicinal formula comprises the following ingredients in weight part: 4 to 6 parts of root bark of white mulberry, 4 to 6 parts of cogongrass rhizome, 4 to 6 parts of fringed iris, 4 to 6 parts of tick, 4 to 6 parts of lophatherum gracile, 4 to 6 parts of cordate houttuynia, 1 to 3 parts of loguat leaf, 1 to 3 parts of hispid arthraxon, 1 to 3 parts of minze, 1 to 3 parts of cape jasmine, 1 to 3 parts of common bombax flower, 1 to 3 parts of oldenlandia diffusa, 1 to 3 parts of herba hyperici japonici, 1 to 3 parts of phyllanthus urinaria, 1 to 3 parts of folium mori, 1 to 3 parts of juncus bufonius and 1 to 3 parts of momordica grosvenori flower. Drinking the cool tea twice a day, a patient attacked by flu and having symptoms of rhinobyon, rhinorrhea, weeping, malaise, immunity weakening and the like can restore health in 3 to 5 days, and the patient with severe symptoms can obviously take a favorable turn in 7 to 10 days. The herbal tea for expelling wind and heat has the advantages of avoiding side effect, along with low cost, good curative effect and quick restoration.

An oral disintegrating tablet of dextromethorphan for treating the cold caused cough, nasal congestion and rhinorrhea is proportionally prepared from dextromethorphan, chlorphenamine, pseudoephedrine, beta-cyclodextrin or ion exchange resin, mannitol or lactose starch, and disintegrant through sieving, flavouring, mixing and die pressing.

The invention discloses violet magnolia rhinitis powder which comprises the following crude drugs in parts by weight: 20 parts of violet magnolia, 60 parts of dahurian patrinia herb, 300 parts of mint, 200 parts of perilla leaves, 400 parts of liquorice, 500 parts of pogostemon cablin, 500 parts of cocklebur fruit, 18 parts of centipeda minima, 100 parts of coptis chinensis, 200 parts of elecampane, 150 parts of ledebouriella seseloides, 150 parts of houttuynia cordata, 280 parts of chrysanthemum, 360 parts of evodia lepta, 30 parts of catechu, 120 parts of indigo naturalis, 50 parts of euphorbia kansui and 25 parts of radix puerariae. The violet magnolia rhinitis powder is scientifically prepared from pure Chinese medicinal herbs and has the effects of expelling wind and removing heat, diminishing inflammation and detoxifies and can be used for treating rhinitis, influenza and rhinorrhea and nasal congestion without relapsing. The violet magnolia has the characteristics of convenient taking, less dosage and favorable curative effect, high total effective rate of more than 99 percent and high effectual rate of more than 95 percent.

The invention relates to a drug for treating allergic rhinitis. The drug is prepared from the following active pharmaceutical ingredients in parts by weight: 8-15 parts of herba ephedrae, 8-15 parts of ramulus cinnamomi, 8-15 parts of radix paeoniae alba, 8-15 parts of rhizoma zingiberis, 5-10 parts of herba asari, 8-18 parts of processed rhizoma pinelliae, 8-18 parts of radix glycyrrhizae preparata, 8-15 parts of fructus schisandrae chinensis, 10-15 parts of radix bupleuri, 10-15 parts of codonopsis pilosula, 10-18 parts of radix saposhnikoviae, 10-15 parts of flos magnolia and 10-15 parts ofChinese dates. The drug provided by the invention has the efficacies of strengthening wei, dispelling wind, warming cold fluid, tonifying lung and spleen, tonifying vital energy, dispelling wind, releasing exterior with pungent-warm, dredging channels and stopping rhinorrhea and is therefore capable of treating allergic rhinitis.

The invention relates to a medical rhinitis antibacterial agent and a preparation method thereof. The antibacterial agent is prepared from small-molecule chitosan quaternary ammonium salt, physiological sea water and traditional Chinese medicine extract, wherein the traditional Chinese medicine extract is obtained by extracting centipede minima, Angelica dahurica, asarum, biond magnolia flowers, artemisia argyi, seeds of Vitis vinifera L., illicium verum and camellia seeds in water. The antibacterial agent has high bactericidal performance as well as good biocompatibility and broad-spectrum bacteria resistance at the same time, can inhibit and prevent tissue on the nasal mucosa or under the nasal mucosa from being infected by germs, repair injured tissue and relieve pains, has good adjunctive treatment and preventing effects on symptoms such as allergic rhinitis, acute or chronic rhinitis, as well as nasal obstruction, rhinalgia, nasal dryness and pruritus, rhinorrhea, nasosinusitis and the like of rihinitis, takes effect rapidly and is free of side effects; rhinitis cannot easily relapse, and the preparation method is simple.

The invention discloses a feed for Persian cats. The feed for the Persian cats consists of chicken blood meal, chicken intestinal meal, sheep visceral powder, chicken liver meal, corn meal, shrimp meal, marine shrimp meal, bitter gourd protein powder, apple protein powder, towel gourd powder, loach powder, vitamin B complex, cod-liver oil, table salt, pine needle meal, safflower powder, liquorice powder, boat-fruited scaphium seed powder, and bitter almond powder. By the scheme, the content of proteins and vitamins in the feed is rich, various nutrient components are reasonably matched, and the demand of the Persian cats on fat, carbohydrates, crude fibers and mineral substances can be met in the feed; in addition, according to the formula, the feed contains Chinese medicinal components such as the natural pine needle meal, the safflower powder, the liquorice powder, the boat-fruited scaphium seed powder, the bitter almond powder and the like, so the feed has good effects of preventing and treating recurrent flu, cough, rhinorrhea, vomit, dehydration, diarrhea, parasites, gastric and intestinal diseases, digestive system diseases and the like of the Persian cats.

The invention discloses a medicine composition for treating rhinitis, and the composition consists of felwort, cocklebur fruit, flower bud of lily magnolia, pseudosciaena crocea, euphorbia kansui, asarum, muskmelon pedicel, dried alum, indigo naturalis, acacia catechu, manyleaf paris rhizome, radices trichosanthis, thunberg fritillary bulb, Guangdong radix curcumae, caulis spatholobi, albizia flower, platycodon grandiflorum, common hogfenneI root, fructus viticis, burdock, smoked plum, fructus rosae laevigatae, semen cuscutae and caulis clematidis armandii. The medicine composition disclosed by the invention is added with general auxiliary materials according to general technique so as to be prepared into clinically acceptable pellet, capsule, slice, particle, powder, decoction or oral liquid. The medicine composition disclosed by the invention has the effects of clearing heat and toxic materials, removing wind, strengthening exterior and curing nasal obstruction, has remarkable effects for treating nasosinusitis, nasal obstruction, rhinorrhea, ache of forehead, rhinitis, nasosinusitis and anaphylactic rhinitis, and causes no toxic and side effects.

The invention relates to an anti-cold medical composition consisting of active components of loratadine, acetaminophen, pseudoephedrine sulfate and pharmaceutically acceptable auxiliary materials. The medical composition is a double-layered sustained-release tablet with a quick release outer layer coating a sustained-release core. The quick release outer layer comprises loratadine and pseudoephedrine sulfate while the sustained-release part comprises acetaminophen and pseudoephedrine sulfate. The double-layered composition is used for relieving sneeze, rhinorrhea, nasal obstruction, laryngeal discomfort, weakness, fever, sore muscle, headache and the like which are caused by cold or seasonal allergic rhinitis.

The invention relates to oral liquid for treating swine unknown high fever and a preparation method thereof. The oral liquid comprises the following Chinese herbal medicines in part by weight: 100 to 200 parts of gypsum, 80 to 150 parts of common anemarrhena rhizome, 80 to 150 parts of liquoric root, 50 to 100 parts of golden thread, 80 to 150 parts of baical skullcap root, 80 to 150 parts of fructus gardeniae seed, 80 to 150 parts of phellodendron, 80 to 150 parts of indigowoad root and 100 to 200 parts of Mongolian dandelion herb, the Chinese herbal medicines are prepared according to a weight ratio and are decocted in water to form an aqueous solution agent. The oral liquid is mainly used for treating symptoms such as failure to abatement of high fever, thick and coarse coats, desuetude in appetite, depressed in spirits, rubefaction and cyanosis of skin of whole bodies, expiratory dyspnea, asthma, rhinorrhea, increase in the secretion of eyes and the like which are caused by accumulation of damp and heat, warm pathogen attacking lung, direct attack of pericardium and failure to abatement of asthenic fever and has the obvious treatment effect on growing and fattening pigs and sows; and the cure rate is more than 85 percent.

The present invention relates to compositions that comprise immediate release and extended release guaifenesin, and extended release hydrocodone bitartrate. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and / or nasal obstruction.

The invention relates to an antipyretic and analgesic and a nonsteroid anti-inflammation analgesic drug and concretely relates to a paracetamol and pseudoephedrine hydrochloride tablet, which is obtained by directly tablet forming dry powder, which is used for remedying the cold. The paracetamol and pseudoephedrine hydrochloride tablet consists of the components of the following weight portions of 500 portions of paracetamol, 30 portions of pseudoephedrine, 48 portions of microcrystalline cellulose, 5.3 portions of vapor phase silicon dioxide and 48 portions of pre-gelatinized starch. The invention is fit for remedying the symptoms caused by the cold of fever, headache, the ache of the whole body and limbs, nasal obstruction, rhinorrhea, sneezes etc.

A treatment regimen for rhinitis with rhinorrhea includes a daytime dosage unit containing medication for treating rhinitis and an anticholinergic agent for treating rhinorrhea, and a nighttime dosage unit containing medication for treating rhinitis and an attenuated dosage of anticholinergic agent or no anticholinergic agent. A pharmaceutical package for treating rhinitis with rhinorrhea includes a daytime dosage unit containing a medication for treating rhinitis and an anticholinergic agent for treating rhinorrhea, a nighttime dosage unit containing medication for treating rhinitis and an attenuated dosage of anticholinergic agent or no anticholinergic agent, indicia to distinguish between the daytime dosage unit and the nighttime dosage unit, instructions for coordinating the daytime dosage unit and the nighttime dosage unit as a treatment regimen for treating rhinitis with rhinorrhea, and a unifying container for housing the daytime dosage unit, the nighttime dosage unit, the indicia, and the instructions.

The invention relates to a loquat floral honey wine and the making method. The loquat floral honey wine is fermented with loquat floral 100 parts, sugar 80-120 parts, fermentation yeast 0.5-4.5 parts, water 200-320 parts and loquat honey 0-8 parts. The making method comprises the following procedures: proceeding with the first fermentation for 30-90 days in the sealable and germ-free tank after mixing the above material in the proper mixing condition; separating wine residue from fermented material and putting the separated wine liquid in the sealable and germ-free tank in order to deposit directly more than one month; proceeding with the second fermentation of the liquid without deposit in the sealable and germ-free tank at least one month. The loquat floral honey wine can be drank as the wine or beverage, which not only has aromatic odor, salubrious taste and pure wine flavour, but also can remove mental fatigue, and prevent or subsidiarily treat seborrheic and rhinorrhea disease and the like.

The invention belongs to the field of medicines, health care and nursing, and relates to a medicine composition for washing a nasal cavity and a preparation method of the medicine composition. The medicine composition can dilute and clean inflammatory secretions of the nasal cavity and harmful air pollutants adsorbed by nasal mucus, dissolve part of pathogenic bacteria and viruses, clean various germs and viruses and improve the physiological environment of the nasal cavity to fulfill the aims of treating various nasal infections and upper respiratory tract infections such as nasal obstruction, rhinorrhea, blood-stained nasal discharge, postnasal drip, sneezing, nasal incrustation, dry and itching nasal cavity, foreign body sensation in the throat, excessive phlegm, expectoration, blood-stained sputum and sphagitis. The medicine composition disclosed by the invention is prepared by mixing 35 to 75 weight parts of sodium chloride and 1 to 4 weight parts of lysozyme, or 35 to 85 weight parts of sodium chloride, 0.1 to 0.5 weight part of glycine and 1 to 4 weight parts of lysozyme. The medicine composition can improve the physiological environment of the nasal cavity more quickly andaccelerate recovery of the nasal cavity. The medicine composition has the advantages of definite effect, stable curative effect, controllability and the like.

The invention discloses stuffy nose relieving essential oil. The stuffy nose relieving essential oil comprises the following raw materials in parts by weight: 10-25 parts of magnolia flower essential oil, 10-20 parts of Chinese angelica essential oil and 10-20 parts of base oil. The stuffy nose relieving essential oil is pure Chinese medicinal essential oil for treating the rhinitis symptoms of nasal obstruction due to cold, sneezing, rhinorrhea and the like. The stuffy nose relieving essential oil is safe and effective to use, is free from toxic and side effects, can be used by adults, and is also suitable for infants.

The invention discloses nasal cream with functions of turbinate hypertrophy elimination and bacteriostasis. The nasal cream comprises raw materials in percentage by mass as follows: 8%-15% of biond magnolia flower, 7%-12% of siberian cocklebur fruit, 8%-13% of small centipeda herb, 3%-7% of radix angelicae, 3%-7% of mint, 3%-7% of largehead atractylodes rhizome, 5%-10% of potassium hydroxide, 0.4%-0.55% of tetracaine hydrochloride powder, 3%-5% of Vaseline, 6%-10% of glycerin and 13.45%-53.6% of distilled water. On the basis of unique formula design and scientific formula, the nasal cream as a traditional Chinese medicine preparation has effects of bacteriostasis, anti-inflammation, blood stasis dissipation, detumescence, antianaphylaxis, exudation reduction and the like, and is applicable to inferior nasal concha mucosa hypertrophy hyperplasia caused by chronic rhinitis, nasosinusitis and allergic rhinitis, all that is required is to use the nasal cream once, clinical curing for nasal obstruction and rhinorrhea can be realized, and if the drug application effect of individual patients is not remarkable, the treatment effect can be realized as well when the nasal cream is applied for the second time 20 days after treatment.

The invention provides a Chinese herbal medicine compound preparation for treating chronic rhinitis-nasosinusitis. The Chinese herbal medicine compound preparation is prepared from the following raw materials in parts by mass: 10-60 parts of kudzuvine root, 10-30 parts of fructus forsythiae, 10-30 parts of cassia twig, 5-15 parts of cocklebur fruits, 10-30 parts of flos magnoliae, 10-40 parts of radix angelicae dahuricae, 10-30 parts of fritillary bulb, 10-60 parts of astragalus, 10-20 parts of ligusticum wallichii, 3-10 parts of asarum, 10-40 parts of desmodium microphyllum, 5-20 parts of gentian, 5-20 parts of centipede, 10-40 parts of fig, 10-40 parts of paederia scandens and 20-50 parts of semen coicis. Clinical preliminary study confirms that the Chinese herbal medicine compound preparation provided by the invention can relieve subjective symptoms such as nasal obstruction and running nose of a patient and relieve nasal mucosal hyperemia, edema, rhinorrhea and the like, and examination by virtue of a nasal endoscope shows that the Chinese herbal medicine compound preparation provided by the invention has better curative effect on the chronic rhinitis-nasosinusitis.

The invention relates to a drug for treating cold. The drug is prepared from the following ingredients in parts by weight: 40-60 parts of forsythia fruit, 40-60 parts of bupleurum root, 15-25 parts of licorice root, 25-35 parts of honeysuckle flower, 20-35 parts of Chuanxiong rhizome, 20-30 parts of black curded bean, 40-60 parts of dandelion, 15-25 parts of lysionotus pauciflorus, 25-35 parts of mint and 10-25 parts of herba schizonepetae. The drug has the effects of clearing heat and detoxifying, dispelling heat and moistening the lung and relieving cough, and is used for treating cold-induced symptoms, such as headache, fever, rhinorrhea, sneezing, coughing, muscle aches and the like. The drug is oral liquid, is a purely-natural traditional Chinese medicine, is free from toxic and side effects and is remarkable in effect.

The compound cold treating preparation is prepared with 11 kinds of Chinese medicinal materials including honeysuckle, mulberry leaf, forsythia, mint, burdock fruit, etc. as well as acetaminophen, and it may be prepared into granule, tablet, capsule, syrup, oral liquid, pill or ointment. The present invention is developed based on the features of wind-heat type common cold and influenza and has excellent curative effect on wind-heat type common cold and influenza with the syndromes of fever, headache, cough, swelling and pain throat, snuffle and rhinorrhea and no toxic side effect.

The invention provides a raindrop-type humidifier. The humidifier comprises a first water trough, at least one water receiving container, a second water trough and a connecting rod. Perforating holes are formed in the bottom of the at least one water receiving container and the bottom of the second water trough respectively, the at least one water receiving container is fixed to the connecting rod through the corresponding perforating hole, the second water trough is fixed to the connecting rod through the corresponding perforating hole, and a plurality of micro-holes are formed in the bottom of the at least one water receiving container and the bottom of the second water trough respectively. The connecting rod comprises an inner diameter channel. The inner diameter channel is higher than the bottom of the second water trough, a drainage tube is arranged in the inner diameter channel in a penetrating mode and connected with a water pump, and the water pump is arranged in the first water trough. By means of the raindrop-type humidifier in the technical scheme, it can be avoided that due to a spray humidification mode, the physiological reactions such as sneezing and rhinorrhea of an allergic constitution user appear, and the overall comfort degree of the user is improved.

The invention provides an anti-inflammatory compound extract comprising Li nationality medicinal materials including aerial parts of Ficus pumila L. and Elaeagnus gonyanthes Benth., its preparation method, and a Li nationality medicinal composition containing the active extract. The extract and composition can be used for treating headache, dizziness, rhinorrhea and nasal obstruction due to acute and chronic sinusitis; have no toxic and side effects; and can be prepared into any oral preparation for treating acute and chronic sinusitis.

The invention discloses a fumigation device for treating allergic rhinitis. The fumigation device for treating allergic rhinitis comprises a bottom supporting part, a heating part, a medicine accommodating part and a fumigation part; the heating part is fixedly arranged on the upper part of a bottom supporting part; the medicine accommodating part is detachably arranged on the upper part of the heating part; and the fumigation part is communicated with the upper part of the medicine accommodating part. The fumigation device provided by the invention is stable to use, not liable to break, highin heating efficiency and high in heating efficiency, can liberate double hands of patients, has high practicability, can adapt to the use requirements of different patients, is convenient to use at home and is also convenient to use in hospitals; the traditional Chinese medicine formula can effectively reduce symptoms of sternutation, rhinorrhea, nasal obstruction, itchy and feverish nasal cavityof patients; and the use method of the fumigation device is simple in use step and easy to operate, and the decocted traditional Chinese medicine has good effect of treating allergic rhinitis and greatly increases the healing rate of the allergic rhinitis of the patients.

The invention relates to medicine and a preparation method thereof, in particular to Mongolian medicine for treating Yamaa disease and a preparation method thereof. The Mongolian medicine is characterized by being composed of, by weight, 63-110 parts of radix aconiti kusnezoffii preparata, 36-120 parts of radix ophiopogonis and 36-100 parts of flos carthami. The Mongolian medicine is prepared by adopting modern processes including powdering and pilling or microwave radiation or solvent extraction. The Mongolian medicine has the advantages that radix ophiopogonis and flos carthami are utilizedto resist, offset or lower toxic and side effect of radix aconite kusnezoffii preparata, efficacy of radix aconite kusnezoffii preparata serving as main medicine on diminishing inflammation, relievingpain and eliminating yellow liquid is brought into full play, and auxiliary medicine having effects of relieving pain, clearing heat and is combined, so that the Mongolian medicine has remarkable treatment effect on symptoms like migraine and headache, toothache, eye rim pain, ocular disorder, rhinorrhea, red apex nasi, nasal cavity itching and difficult breathing caused by Yamaa disease; the Mongolian medicine is direct in efficacy, quick in action, few in toxic and side effect, safe to take, low in cost and considerable in popularization and application prospect.

The invention discloses a traditional Chinese medicine preparation for treating infantile hand-foot-mouth disease and a preparation method, belonging to the field of traditional Chinese medicines. The traditional Chinese medicine preparation is prepared from the following raw materials as effective ingredients: isatis root, smallfruit fig aerial root, carrot, viburnum dilatatum, ligustrum sinense, cortex dictamni, tamarisk, centella, stinkweed, chushan lip-fern herb, rhizoma cimicifugae, nutgall, mint, myricaria germanica, licorice and acacia catechu. The medicinal materials selected by the traditional Chinese medicine preparation are appropriate in compatibility and are combined to achieve the effects on clearing away heat and toxic materials, dispelling wind and arresting itching, strengthening superficial body resistance and promoting eruption, eliminating dampness and astringing sores, invigorating qi and strengthening the middle-jiao, relieving spasm and pain and the like; the traditional Chinese medicine preparation has the advantages of exact curative effect, high effect taking speed, high cure rate, no toxic or side effect, safety and reliability when used for treating symptoms, such as cough, herpes, herpes labialis, rhinorrhea, salivation, stomatalgia, corrosive blister, blister or bleb injury, meloschisis and tongue and gum painful miliary blister, caused by infantile hand-foot-mouth disease; and therefore, the traditional Chinese medicine preparation can be widely used for clinically treating infantile hand-foot-mouth disease.